C3 - complement C3 Gene
Also Known as C3d
Species: Sus scrofa
Gene Type: protein coding
Gene ID: 397072
C3 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_214009.1 | NP_999174.1 | complement C3 precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
complement C3 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-127105 | Iptacopan | Inhibitor | 99.95% | Yes |
| HY-127105A | Iptacopan hydrochloride | Inhibitor | 99.88% | Yes |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99050 | Sutimlimab | Inhibitor | 98.81% | Unkown |
Clinical Phase
Bioactive Molecules
(15)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-14605BS | Rasagiline-13C3 mesylate racemic | Inhibitor | / | Phase 4 |
| HY-P3252A | Pegcetacoplan acetate | Inhibitor | 99.92% | Phase 3 |
| HY-106178 | PMX-53 | Antagonist | 99.95% | Phase 2 |
| HY-P1717A | AMY-101 TFA | Inhibitor | 99.92% | Phase 2 |
| HY-N9481 | Lipoteichoic acid | / | Phase 2 | |
| HY-19903 | ASP-9521 | 98.0% | Phase 2 | |
| HY-124573 | (R)-Odafosfamide | 98.52% | Phase 2 | |
| HY-P3204 | POT-4 | Inhibitor | 98.88% | Phase 2 |
| HY-P2141A | TRV-120027 TFA | Agonist | 99.62% | Phase 2 |
| HY-149040 | Odafosfamide | 99.06% | Phase 2 | |
| HY-156701 | BAY-1128688 | / | Phase 2 | |
| HY-P3204A | POT-4 TFA | Inhibitor | / | Phase 2 |
| HY-P1717 | AMY-101 | Inhibitor | 99.86% | Phase 1 |
| HY-10819 | AG2034 | / | Phase 1 | |
| HY-114913 | Fenarimol | Inhibitor | 99.78% | Phase 1 |
Bioactive MoleculesInhibitory Antibodies
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P990091 | Riliprubart | Inhibitor | 99.90% | Phase 3 |
| HY-P990025 | Empasiprubart | ≥99.0% | Phase 3 | |
| HY-P991022 | Ruxoprubart | Inhibitor | 95.541% | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(745)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-101502A | SB290157 trifluoroacetate | Antagonist | 99.87% | Unkown |
| HY-12481 | SAR405 | Inhibitor | 99.74% | Unkown |
| HY-N0376 | Liquiritin | 99.99% | Unkown | |
| HY-132295 | Azenosertib | Inhibitor | 99.96% | Unkown |
| HY-Y0479S | L-Lactic acid-13C3 | 99.9% | Unkown | |
| HY-138161 | JR14a | Antagonist | 99.77% | Unkown |
| HY-P1036 | Compstatin | Inhibitor | 99.83% | Unkown |
| HY-15978 | P7C3-A20 | 99.32% | Unkown | |
| HY-W021005 | Silver bis(trifluoromethanesulfonyl)imide | 99.90% | Unkown | |
| HY-P2848 | Cholesterol oxidase, Microorganism | ≥90.0% | Unkown | |
| HY-N0650S | L-Serine-13C3 | 99.95% | Unkown | |
| HY-W015913S | Pyruvic acid-13C3 sodium | Inhibitor | 99.7% | Unkown |
| HY-NP004 | Cobra Venom Factor | Activator | 99.07% | Unkown |
| HY-Y0479AS | L-Lactic acid-13C3 sodium (20% w/w in water) | 99.91% | Unkown | |
| HY-P1717B | AMY-101 acetate | Inhibitor | 99.93% | Unkown |
| HY-103007 | TC-G-1008 | Agonist | 99.36% | Unkown |
| HY-150644 | S07-2010 | 98.35% | Unkown | |
| HY-Y0337S | L-Cysteine-13C3,15N | 99.9% | Unkown | |
| HY-108568 | 15-Deoxy-Δ-12,14-prostaglandin J2 | Agonist | ≥99.0% | Unkown |
| HY-B1659S5 | Glycerol-13C3 | 99.69% | Unkown | |
| HY-P1345A | TLQP-21 TFA | Agonist | 99.90% | Unkown |
| HY-128358 | MR-L2 | Activator | 98.63% | Unkown |
| HY-107379 | AKR1C3-IN-1 | 98.21% | Unkown | |
| HY-134222A | N-Acetylserine | Inhibitor | 98.0% | Unkown |
| HY-15976 | P7C3 | 99.66% | Unkown | |
| HY-P2141 | TRV-120027 | Agonist | 98.21% | Unkown |
| HY-128132 | C3a receptor agonist 1 | Agonist | 98.16% | Unkown |
| HY-112633 | SMN-C3 | Modulator | 99.48% | Unkown |
| HY-133618 | Pomalidomide-C3-adavosertib | 99.84% | Unkown | |
| HY-W004701 | Br-C3-methyl ester | 99.12% | Unkown | |
| HY-161022A | FL118-C3-O-C-amide-C-NH2 formate | 96.49% | Unkown | |
| HY-125877 | PROTAC Mcl1 degrader-1 | Inhibitor | 98.13% | Unkown |
| HY-126521 | N3-C3-NHS ester | 99.85% | Unkown | |
| HY-Y0337S4 | L-Cysteine-13C3 | 99.9% | Unkown | |
| HY-113128S | sn-Glycerol 3-phosphate-13C3 disodium | 98.7% | Unkown | |
| HY-N0650S5 | L-Serine-13C3,15N | 99.9% | Unkown | |
| HY-162266 | C3TD879 | 98.61% | Unkown | |
| HY-40145 | 1-Boc-3-iodoazetidine | 99.79% | Unkown | |
| HY-E70528 | HRV-3C protease fuses with GST | / | Unkown | |
| HY-138557 | AKR1C3-IN-4 | 99.77% | Unkown | |
| HY-P1505A | C3a (70-77) TFA | 99.79% | Unkown | |
| HY-152189 | S19-1035 | 99.93% | Unkown | |
| HY-B1337S4 | Choline Chloride-13C3 | 99.69% | Unkown | |
| HY-140928 | Biotin-PEG4-amino-t-Bu-DADPS-C3-alykne | 95.0% | Unkown | |
| HY-N6978 | Ascr#5 | 98.0% | Unkown | |
| HY-107551 | Hh Pathway-IN-1 | 99.06% | Unkown | |
| HY-117992 | BR103 | 99.66% | Unkown | |
| HY-N4134 | Ciwujianoside C3 | Inhibitor | 99.65% | Unkown |
| HY-145225 | DLin-K-C3-DMA | Chemical | 98.59% | Unkown |
| HY-B0430S | Pantothenic acid-13C3,15N hemicalcium | 99.3% | Unkown | |
| HY-D1581 | BODIPY 505/515-8-C3-COOH | 99.92% | Unkown | |
| HY-W008567 | N-Deschlorobenzoyl indomethacin | 95.0% | Unkown | |
| HY-147090 | Tazemetostat de(methylene morpholine)-O-C3-O-C-COOH | Degrader | 99.06% | Unkown |
| HY-163962 | L18I | 99.89% | Unkown | |
| HY-N0229S8 | L-Alanine-13C3 | 99.90% | Unkown | |
| HY-N10361 | Drupanin | 99.35% | Unkown | |
| HY-RI00407 | hsa-miR-200c-3p inhibitor | 96.28% | Unkown | |
| HY-144432S | D-Pantothenic acid-13C3,15N hemicalcium hemihydrate | 99.7% | Unkown | |
| HY-163032 | FABP4-IN-3 | Inhibitor | 99.64% | Unkown |
| HY-I0400S3 | N-Acetylneuraminic acid-13C-3 | 99.0% | Unkown | |
| HY-100683 | A12B4C3 | Inhibitor | 98.06% | Unkown |
| HY-148142 | Pomalidomide-C3-NHS ester | 98.70% | Unkown | |
| HY-W683760 | N-Nitrosonornicotine | 99.97% | Unkown | |
| HY-B1773AS3 | Sodium propionate-13C3 | 99.45% | Unkown | |
| HY-171544 | AGS-16C3F | 99.81% | Unkown | |
| HY-109154 | Obafistat | Inhibitor | 99.92% | Unkown |
| HY-145127 | ETZ | 99.84% | Unkown | |
| HY-155035 | S07-1066 | 99.48% | Unkown | |
| HY-N0229S10 | L-Alanine-13C3,15N | 98.0% | Unkown | |
| HY-N0680S3 | Thiamine-13C3 hydrochloride | 99.9% | Unkown | |
| HY-N1981S | Triolein-13C3 | Inhibitor | 98.00% | Unkown |
| HY-W004617 | 2,4,6-Tris(4-carboxyphenyl)-1,3,5-triazine | 99.01% | Unkown | |
| HY-W004640 | N-Boc-C1-PEG3-C3-NH2 | 98.0% | Unkown | |
| HY-W007376S | Indole-3-carboxaldehyde-13C | 97.39% | Unkown | |
| HY-40354S | Tofacitinib-13C3 | 99.77% | Unkown | |
| HY-P1036A | Compstatin TFA | Inhibitor | 99.11% | Unkown |
| HY-D1342 | Coumberol | 99.99% | Unkown | |
| HY-R00407 | hsa-miR-200c-3p mimic | 95.41% | Unkown | |
| HY-B0710S | Betaine-13C3 | 99.86% | Unkown | |
| HY-131185 | Pomalidomide-amido-C3-COOH | 99.69% | Unkown | |
| HY-130711B | (S,R,S)-AHPC-C3-NH2 hydrochloride | 96.68% | Unkown | |
| HY-140902A | Biotin-PEG3-C3-NH2 | 97.0% | Unkown | |
| HY-N0322S4 | Cholesterol-13C3 | Agonist | 98.80% | Unkown |
| HY-B0356AS1 | Ciprofloxacin-13C3,15N monohydrochloride | 99.9% | Unkown | |
| HY-W077634 | 3-Amino-5-hydroxybenzoic acid | 99.83% | Unkown | |
| HY-12481A | SAR405 R enantiomer | Control | 99.94% | Unkown |
| HY-130142A | Biotinyl-NH-PEG3-C3-amido-C3-COOH | 99.25% | Unkown | |
| HY-131888 | Pomalidomide-C3-NH2 hydrochloride | 99.72% | Unkown | |
| HY-133479 | Tetrazine-Ph-NHCO-C3-NHS ester | 98.40% | Unkown | |
| HY-152188 | AKR1C3-IN-9 | 99.77% | Unkown | |
| HY-157510 | Thalidomide-O-C3-azide | 98.41% | Unkown | |
| HY-159604 | METTL3-IN-9 | Inhibitor | 95.30% | Unkown |
| HY-172314 | ACHM-025 | 98.06% | Unkown | |
| HY-N0351S | p-Coumaric acid-13C3 | 99.12% | Unkown | |
| HY-N3205 | Neochamaejasmin B | 98.53% | Unkown | |
| HY-W010407S | Cyanuric acid-13C3 | 98.0% | Unkown | |
| HY-W013061S1 | Propane-1,2,3-triyl tripalmitate-13C3 | 98.0% | Unkown | |
| HY-113008AS | cis-Urocanic acid-13C3 | Agonist | 99.46% | Unkown |
| HY-R04629 | hsa-miR-29c-3p mimic | 98.48% | Unkown | |
| HY-W414731 | N-(3-Methylphenyl)anthranilic acid | 99.82% | Unkown | |
| HY-N0650S3 | L-Serine-13C3,15N,d3 | ≥99.90% | Unkown | |
| HY-100196S1 | Pyrroloquinoline quinone-13C3 sodium | 99.29% | Unkown | |
| HY-103608 | (S,R,S)-AHPC-(C3-PEG)2-C6-Cl | 98.85% | Unkown | |
| HY-108568S | 15-Deoxy-Δ-12,14-prostaglandin J2-d4 | Agonist | 98.10% | Unkown |
| HY-128856 | P7C3-OMe | 98.26% | Unkown | |
| HY-133584 | Bis-SS-C3-NHS ester | 98.0% | Unkown | |
| HY-15129S | O-Phospho-L-serine-13C3,15N | Modulator | 99.19% | Unkown |
| HY-158118 | Lys(CO-C3-p-I-Ph)-OMe | 97.19% | Unkown | |
| HY-160897 | Methoxy-PEG2000-C3-amide-C2-Mal | 99.69% | Unkown | |
| HY-161022S1 | FL118-C3-O-C-amide-C-NH2-d5 formate | / | Unkown | |
| HY-162816 | PROTAC HPK1 Degrader-3 | / | Unkown | |
| HY-163940 | LX1 | 99.13% | Unkown | |
| HY-N0136S1 | (±)-Taxifolin-13C3 | Inhibitor | 99.63% | Unkown |
| HY-N0230S | β-Alanine-13C3,15N | 99.99% | Unkown | |
| HY-N0898S | Catechin-13C3 | 98.06% | Unkown | |
| HY-N7404S1 | Nε,Nε,Nε-Trimethyllysine-13C3 chloride | 98.0% | Unkown | |
| HY-P1640 | (Trp63,Trp64)-C3a(63-77) | Agonist | 99.23% | Unkown |
| HY-R00006 | hsa-let-7c-3p mimic | 93.63% | Unkown | |
| HY-R00717 | hsa-miR-34c-3p mimic | 94.18% | Unkown | |
| HY-R01568 | hsa-miR-518c-3p mimic | 92.33% | Unkown | |
| HY-R01678 | hsa-miR-548c-3p mimic | 92.16% | Unkown | |
| HY-W442078 | Iodine-C3-O-C3-PEG-Boc | ≥98.0% | Unkown | |
| HY-113294S | 3-Hydroxykynurenine-13C3,15N | Inducer | 99.0% | Unkown |
| HY-171115 | Pyrone-211 | 99.32% | Unkown | |
| HY-403561 | 2-MSP-C3-NHS ester | / | Unkown | |
| HY-W1120221 | Lenalidomide-C3-NH2 | / | Unkown | |
| HY-W336094 | 1,3-Glyceryl dilinoleate | / | Unkown | |
| HY-115560A | Thalidomide-O-amido-C3-NH2 TFA | Inducer | 99.58% | Unkown |
| HY-131646 | Thalidomide-O-amido-C3-PEG3-C1-NH2 | Inducer | 99.08% | Unkown |
| HY-N1428S3 | Citric acid-13C3 | Inhibitor | 98% | Unkown |
| HY-103612 | Thalidomide-O-amido-C3-COOH | Inducer | 98.43% | Unkown |
| HY-111297 | BMVC4 | / | Unkown | |
| HY-116170 | SN34037 | Inhibitor | 99.02% | Unkown |
| HY-120903 | DBCO-C3-Acid | 99.68% | Unkown | |
| HY-131455A | Biotin-C1-PEG3-C3-amido-C5-Gly-Arg-Gly-N3 TFA | 98.0% | Unkown | |
| HY-135306 | Cl-C6-PEG4-C3-COOH | 99.65% | Unkown | |
| HY-138847A | Thalidomide-4-O-C3-NH2 hydrochloride | Inducer | / | Unkown |
| HY-140808 | Azido-PEG3-C3-OH | 98.0% | Unkown | |
| HY-140841 | APN-C3-PEG4-azide | 97.97% | Unkown | |
| HY-148608 | LysoPalloT-NH-amide-C3-ph-m-O-C11 | Agonist | / | Unkown |
| HY-158122 | Lys(CO-C3-p-I-Ph)-O-tBu | 98.14% | Unkown | |
| HY-161022 | FL118-C3-O-C-amide-C-NH2 | / | Unkown | |
| HY-161022S | FL118-C3-O-C-amide-C-NH2-d5 | / | Unkown | |
| HY-161708 | PROTAC FLT3/CDKs degrader-1 | Degrader | / | Unkown |
| HY-163678 | Pomalidomide-CO-C7-NH-CO-C3-COOH | 98.55% | Unkown | |
| HY-176084 | RJG-2051 | 99.42% | Unkown | |
| HY-B0150S1 | Nicotinamide-15N,13C3 | Inhibitor | 98.88% | Unkown |
| HY-B0234S | Estrone-13C3 | Agonist | 98.0% | Unkown |
| HY-B0389S9 | D-Glucose-13C3-2 | 98% | Unkown | |
| HY-B0495S | Lamotrigine-13C3,d3 | 97.46% | Unkown | |
| HY-B0891S1 | 17α-Hydroxyprogesterone-13C3 | Agonist | 98.9% | Unkown |
| HY-B1804S | Tricaprilin-13C3 | 98.0% | Unkown | |
| HY-D1056A5 | Lipopolysaccharides, from E. coli K-235 | Activator | / | Unkown |
| HY-N0172S | Caffeic acid-13C3 | Inhibitor | / | Unkown |
| HY-N0437S2 | Progesterone-13C3 | Agonist | 99.60% | Unkown |
| HY-N0464S | Quinic acid-13C3 | Inhibitor | 99.5% | Unkown |
| HY-N0610AS2 | Cinnamic acid-13C3 | 99.91% | Unkown | |
| HY-N0771S6 | L-Cysteine-13C3,15N,d3 | 99.6% | Unkown | |
| HY-N2041S4 | Myristic acid-13C3 | 99.9% | Unkown | |
| HY-N2362S1 | DL-Alanine-13C-3 | 98.0% | Unkown | |
| HY-P1398 | Compstatin control peptide | Control | 99.95% | Unkown |
| HY-P1505 | C3a (70-77) | / | Unkown | |
| HY-P2325 | Exoenzyme C3, clostridium botulinum | Inhibitor | / | Unkown |
| HY-R00333 | hsa-miR-181c-3p mimic | 94.69% | Unkown | |
| HY-R00407A | hsa-miR-200c-3p agomir | / | Unkown | |
| HY-R00840 | hsa-miR-376c-3p mimic | 93.13% | Unkown | |
| HY-R01112 | hsa-miR-449c-3p mimic | 99.11% | Unkown | |
| HY-R02698 | mmu-miR-181c-3p mimic | 99.43% | Unkown | |
| HY-R02897 | mmu-miR-302c-3p mimic | 98.79% | Unkown | |
| HY-RI00333 | hsa-miR-181c-3p inhibitor | 99.68% | Unkown | |
| HY-RI00840 | hsa-miR-376c-3p inhibitor | 99.33% | Unkown | |
| HY-RS01743 | C3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS10521 | Pik3c3 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W010421S | Ammelide-13C3 | 99.85% | Unkown | |
| HY-W024692 | Indomethacin methylester | 99.92% | Unkown | |
| HY-W099927 | [C3MPr]NTf2 | 97.0% | Unkown | |
| HY-W654331 | Quinolinic acid-13C3, 15N | 99.76% | Unkown | |
| HY-Y1117S2 | Melamine-15N3,13C3 | 96.08% | Unkown | |
| HY-Y1662 | D-Aminoacylase | / | Unkown | |
| HY-131800A | 3'-NH2-ATP tetrasodium, 100 mM Solution | 98.70% | Unkown | |
| HY-158861 | C3-K2-E14 | 98.5% | Unkown | |
| HY-160773A | DBCO-C3-amide-PEG6-NHS ester | 95.20% | Unkown | |
| HY-19903R | ASP-9521 (Standard) | 94.47% | Unkown | |
| HY-43193 | Cl-C6-PEG3-C3-acid | ≥97.0% | Unkown | |
| HY-RI04616 | hsa-miR-29c-3p inhibitor | 97.78% | Unkown | |
| HY-RS21501 | C3ar1 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W046063 | O-Phthalimide-C3-acid | / | Unkown | |
| HY-W069545 | (S)-1-Tetralol | 99.75% | Unkown | |
| HY-W112031 | OH-PEG2-C3-NH2 | ≥95.0% | Unkown | |
| HY-W392808 | Spacer phosphoramidite C3 | 98.0% | Unkown | |
| HY-W422359A | 2-Aminopurine-O-Ph-NHCO-C3-COOH hydrochloride | 95.27% | Unkown | |
| HY-W590573 | C3 Ceramide | 98.49% | Unkown | |
| HY-W686763 | Triacetylphloroglucinol | 99.95% | Unkown | |
| HY-W747332 | Pyruvic aldehyde-13C3 (20% in water) | / | Unkown | |
| HY-W769017 | Thiothiamine-13C3 | / | Unkown | |
| HY-W018171S2 | 3,5,6-Trichloro-2-pyridinol-13C3 | / | Unkown | |
| HY-18085S2 | Quercetin-13C3 | / | Unkown | |
| HY-115560 | Thalidomide-O-amido-C3-NH2 | Inducer | / | Unkown |
| HY-116084S1 | Trimethylamine-N-oxide-13C3 | Activator | / | Unkown |
| HY-130711A | (S,R,S)-AHPC-C3-NH2 TFA | / | Unkown | |
| HY-131876 | Thalidomide-O-C3-acid | Inducer | / | Unkown |
| HY-135900 | Aniline-MPB-amino-C3-PBD | Inhibitor | / | Unkown |
| HY-15097S | Myricetin-13C3 | Inducer | / | Unkown |
| HY-B0412S3 | Estriol-13C3 | Antagonist | / | Unkown |
| HY-130711 | (S,R,S)-AHPC-C3-NH2 | / | Unkown | |
| HY-131186 | Pomalidomide-amido-C3-piperazine-N-Boc | / | Unkown | |
| HY-105414 | Esterbut-3 | / | Unkown | |
| HY-105969 | Dichloromethotrexate | / | Unkown | |
| HY-111843 | Ch55-O-C3-NH2 | / | Unkown | |
| HY-113008S1 | Urocanic acid-13C3 | / | Unkown | |
| HY-113357S | m-Coumaric acid-13C3 | / | Unkown | |
| HY-114773 | N-Undecanoyl-L-homoserine lactone | / | Unkown | |
| HY-115902 | FGFR4-IN-7 | / | Unkown | |
| HY-116021S | Buquinolate-13C3 | Inhibitor | / | Unkown |
| HY-116025 | APN-C3-PEG4-alkyne | / | Unkown | |
| HY-116295 | MRS2690 | / | Unkown | |
| HY-116295A | MRS2690 disodium | / | Unkown | |
| HY-121656 | AKR1C2/3-IN-2 | Inhibitor | / | Unkown |
| HY-12210 | (S)-BI-1001 | Inhibitor | / | Unkown |
| HY-12216S | Resmetirom-13C3,15N | Agonist | / | Unkown |
| HY-122888 | MPT0L145 | / | Unkown | |
| HY-123732 | CRT0083914 | / | Unkown | |
| HY-124456 | Unguinol | Inhibitor | / | Unkown |
| HY-12542S | Dantrolene-13C3 | Inhibitor | 99.0% | Unkown |
| HY-126287 | JND4135 | / | Unkown | |
| HY-127105B | Iptacopan TFA | Inhibitor | / | Unkown |
| HY-128748S4 | DL-Glyceraldehyde-13C3 | / | Unkown | |
| HY-128753S4 | D-Lyxose-13C-3 | / | Unkown | |
| HY-130142 | Biotinyl-NH-PEG3-C3-amido-C3-COOH (DIPEA) | / | Unkown | |
| HY-130585S | Estradiol undecylate-13C3 | / | Unkown | |
| HY-130711C | (S,R,S)-AHPC-C3-NH2 dihydrochloride | / | Unkown | |
| HY-131184 | N-Boc-piperazine-C3-COOH | / | Unkown | |
| HY-131190 | N-Boc-SBP-0636457-O-C3-COOH | / | Unkown | |
| HY-131606S | Cidofovir diphosphate-13C3 | Inhibitor | / | Unkown |
| HY-131801A | 3'-NH2-GTP tetrasodium | / | Unkown | |
| HY-131888A | Pomalidomide-C3-NH2 | / | Unkown | |
| HY-133403A | Biotin-C1-PEG3-C3-amine TFA | / | Unkown | |
| HY-133585 | Bis-SS-C3-sulfo-NHS ester | / | Unkown | |
| HY-133702 | Aniline-piperazine-C3-NH-Boc | / | Unkown | |
| HY-134679 | N-Boc-C1-PEG5-C3-NH2 | / | Unkown | |
| HY-134692 | Azido-C1-PEG3-C3-NH2 | / | Unkown | |
| HY-134693 | Azido-C1-PEG4-C3-NH2 | / | Unkown | |
| HY-134749 | Propargyl-PEG2-urea-C3-triethoxysilane | / | Unkown | |
| HY-135901 | Py-MPB-amino-C3-PBD | Inhibitor | / | Unkown |
| HY-13599S3 | Cladribine-13C3,15N3 | / | Unkown | |
| HY-13632S1 | Exemestane-13C3 | Inhibitor | / | Unkown |
| HY-136457S | 2-NP-AHD-13C3 | / | Unkown | |
| HY-137842 | L-Alanine-2-naphthylamide | Substrate | / | Unkown |
| HY-138847 | Thalidomide-O-C3-NH2 | Inducer | / | Unkown |
| HY-138850 | Thalidomide-NH-amido-C3-NH2 | Inducer | / | Unkown |
| HY-138850A | Thalidomide-NH-amido-C3-NH2 hydrochloride | Inducer | / | Unkown |
| HY-139145S | Etbicyphat-13C3 | / | Unkown | |
| HY-139427S | 3-Methylglutaconic acid-13C3 | / | Unkown | |
| HY-139545 | Thalidomide-4-C3-NH2 hydrochloride | Inducer | / | Unkown |
| HY-139721 | Tenofovir-C3-O-C15-CF3 ammonium | Inhibitor | / | Unkown |
| HY-139722 | Tenofovir-C3-O-C12-trimethylsilylacetylene ammonium | Inhibitor | / | Unkown |
| HY-140019 | Azido-PEG3-amide-C3-triethoxysilane | / | Unkown | |
| HY-140288 | DBCO-C3-PEG4-amine | / | Unkown | |
| HY-140295 | DBCO-C3-PEG4-NH-Boc | / | Unkown | |
| HY-140347 | APN-C3-NH-Boc | / | Unkown | |
| HY-140478 | Boc-NH-PEG4-C3-acid | / | Unkown | |
| HY-140902 | rel-Biotin-PEG3-C3-NH2 | / | Unkown | |
| HY-140927 | Azido-C3-UV-biotin | / | Unkown | |
| HY-141065 | N-(azide-PEG3)-N'-(Amine-C3-Amide-PEG4)-Cy5 | / | Unkown | |
| HY-141407 | m-PEG3-amido-C3-triethoxysilane | / | Unkown | |
| HY-141597 | Acid-C3-SSPy | / | Unkown | |
| HY-141651 | (S,R,S)-AHPC-C3-COOH | / | Unkown | |
| HY-141857S | 5-(4-Hydroxyphenyl)-5-phenyl-d5-hydantoin-2,4,5-13C3 | / | Unkown | |
| HY-141893 | 3-Cyanovinylcarbazole phosphoramidite | Inhibitor | / | Unkown |
| HY-141901S2 | Dehydroepiandrosterone-13C3 | / | Unkown | |
| HY-141907S | 17β-Estradiol-13C3 | 98.1% | Unkown | |
| HY-142140S | 3-epi-25-Hydroxy Vitamin D3-d6 | / | Unkown | |
| HY-143342 | LEB-03-144 | / | Unkown | |
| HY-143400 | HSP70-IN-3 | Inhibitor | / | Unkown |
| HY-143439 | LX-039 | Antagonist | / | Unkown |
| HY-143687S | 3-Cyano Gimeracil methyl ether-13C3 | / | Unkown | |
| HY-144749 | AKR1C3-IN-5 | / | Unkown | |
| HY-145253 | Tri(TLR4-IN-C34-C2-amide-PEG1)-amide-C3-COOH | Inhibitor | / | Unkown |
| HY-145254 | Tri(TLR4-IN-C34-PEG2-amide-PEG1)-amide-C3-COOH | Inhibitor | / | Unkown |
| HY-145255 | Tri(TLR4-IN-C34-C2-amide-C3-amide-PEG1)-amide-C3-COOH | Inhibitor | / | Unkown |
| HY-14605S | Rasagiline-13C3 mesylate | / | Unkown | |
| HY-146573 | AKR1C3-IN-6 | / | Unkown | |
| HY-146574 | AKR1C3-IN-7 | / | Unkown | |
| HY-146575 | AKR1C3-IN-8 | / | Unkown | |
| HY-148471A | C3-Amide-C4-NH2 | / | Unkown | |
| HY-149560 | Thalidomide-5-O-C3-NH2 hydrochloride | Inducer | 99.08% | Unkown |
| HY-150624 | SARS-CoV-2 nsp13-IN-3 | Inhibitor | / | Unkown |
| HY-150646 | S07-2009 | / | Unkown | |
| HY-150648 | S07-2008 | / | Unkown | |
| HY-150649 | S07-2005 (racemic) | / | Unkown | |
| HY-150650 | S07-2001 | / | Unkown | |
| HY-150658S2 | DMT-2′O-TBDMS-rA(ac) phosphoramidite-13C3 | / | Unkown | |
| HY-151997S | 1,2-Dioleoyl-3-lauroyl-rac-glycerol-13C3 | / | Unkown | |
| HY-153456 | Hedgehog IN-2 | Inhibitor | / | Unkown |
| HY-153539 | AP-C3 | Inhibitor | / | Unkown |
| HY-153540 | AP-C4 | Inhibitor | / | Unkown |
| HY-15398S1 | Vitamin D3-13C3 | Activator | / | Unkown |
| HY-155259 | Pomalidomide-5-C3-NH2 hydrochloride | 96.02% | Unkown | |
| HY-155502 | AKR1C3-IN-10 | / | Unkown | |
| HY-155716 | G43-C3-TEG | Inhibitor | / | Unkown |
| HY-157541S | 2-Chloro-1,3-propanediol-13C3 | / | Unkown | |
| HY-157810 | AKR1C3-IN-11 | / | Unkown | |
| HY-158383 | Pomalidomide-CO-C3-PEG4-C6-NH2 | / | Unkown | |
| HY-158732 | MAO-B-IN-33 | Inhibitor | / | Unkown |
| HY-158994S | MEGDSRGG-(Ala-13C3,15N)-GGEA-(Leu-13C6,15N)-DPESAASSLSGAS TFA | / | Unkown | |
| HY-15977 | (S)-P7C3-OMe | / | Unkown | |
| HY-161131 | Lenalidomide 4'-alkyl-C3-azide | / | Unkown | |
| HY-161468 | Thalidomide-N-C3-O-C4-O-C3-OH | Inducer | / | Unkown |
| HY-161653 | Boc-NH-C3-O-Ph(NO2)-methylester-O-pyrrolidine-2,5-dione | / | Unkown | |
| HY-161832 | (S,R,S)-Me-AHPC-amide-C3-alkyne | / | Unkown | |
| HY-161839 | AKR1C2/3-IN-1 | / | Unkown | |
| HY-162714 | C3N-Dbn-Trp2 | Inhibitor | / | Unkown |
| HY-163223 | (S,R,S)-AHPC-CO-CH2-piperazine-C3-piperazine-Boc | / | Unkown | |
| HY-163323 | AKR1C3-IN-12 | / | Unkown | |
| HY-163609 | PROTAC AKR1C3 degrader-1 | / | Unkown | |
| HY-163610 | AKR1C3-IN-13 | / | Unkown | |
| HY-163758 | COOH-C3-CONH-C7-COOH | / | Unkown | |
| HY-163784 | AKR1C3-IN-14 | / | Unkown | |
| HY-163821 | HO-CONH-C3-PEG3-NH2 | / | Unkown | |
| HY-163903 | OH-C2-PEG3-NHCO-C3-COOH | / | Unkown | |
| HY-163904 | (S,R,R)-VH032-CO-C3-CONH-C2-PEG3-OH | / | Unkown | |
| HY-163964 | Lenalidomide-C3-PEG3-N3 | / | Unkown | |
| HY-164085 | Azide-C3-NHCO-C3-NHS ester | / | Unkown | |
| HY-164909 | PZ-3022 | / | Unkown | |
| HY-168239 | Thalidomide-piperidine-CO-piperazine-C-3-Br-Ph | / | Unkown | |
| HY-169401 | L321-NH-C3-PEG3-C1-NH2 | / | Unkown | |
| HY-170531 | SR 142948-C3-NHMe | / | Unkown | |
| HY-170808 | PROTAC BRD4 Degrader-28 | Degrader | / | Unkown |
| HY-170867 | Nrf2/HO-1 activator 3 | / | Unkown | |
| HY-170978 | PROTAC CDK9 degrader-11 | Degrader | / | Unkown |
| HY-172804 | SDH-IN-26 | / | Unkown | |
| HY-173132 | AKR1Cs-IN-1 | / | Unkown | |
| HY-173453 | AKR1C3-IN-15 | / | Unkown | |
| HY-173500 | MG-3C | / | Unkown | |
| HY-174384 | MET Transcription-IN-1 | / | Unkown | |
| HY-17461S | Cortisone-13C3 | Agonist | / | Unkown |
| HY-175074 | C3 BODIPY Ganglioside GM1 (d18:1/3:0) ammonium | / | Unkown | |
| HY-175193 | N-Deshydroxyethyl Dasatinib-C3-NH2 | Inhibitor | / | Unkown |
| HY-175754 | C3TD078 | Inhibitor | / | Unkown |
| HY-175936 | NH2-C3-piperazin-Pip-Boc | / | Unkown | |
| HY-176037 | Boc-C3-amide-C10-amine | / | Unkown | |
| HY-176243 | 15-Deoxy-Δ12,14-Prostaglandin J2-2-glyceryl ester | Agonist | / | Unkown |
| HY-176335 | TBK1 ligand 2-C-O-C4-O-C3-O-C-amide | Inhibitor | / | Unkown |
| HY-176363 | Adavosertib-C3-NH-Boc | Inhibitor | / | Unkown |
| HY-176364 | AZD9496-O-C3-O-C3-O-C-acid | Inhibitor | / | Unkown |
| HY-176385 | 3-Fluoro-desmethyl-cabozantinib-C3-O-C3-PEG-acid | Ligand | / | Unkown |
| HY-176978 | (S,S,S)-Me-AHPC-amide-C3-alkyne | / | Unkown | |
| HY-177148 | G256 | Substrate | / | Unkown |
| HY-177148A | G256 dihydrochloride | Substrate | / | Unkown |
| HY-177621 | Cevolisiran | Inhibitor | / | Unkown |
| HY-177621A | Cevolisiran sodium | Inhibitor | / | Unkown |
| HY-177802 | C3 sodium | Inhibitor | / | Unkown |
| HY-178284 | Factor B-IN-7 | Inhibitor | / | Unkown |
| HY-178299S | 3-Amino-5-hydroxybenzoic acid-13C | / | Unkown | |
| HY-179170S | Malonyl CoA-13C3 lithium | Inhibitor | / | Unkown |
| HY-179863 | BODIPY 505/515-C3-CONH-Oleic acid | / | Unkown | |
| HY-180562 | KARS-IN-1 | Inhibitor | / | Unkown |
| HY-180971 | Ceritinib-amide-C3-acid | Ligand | / | Unkown |
| HY-180978 | H2N-PEG3-C2-Trizole-C3-COOH | / | Unkown | |
| HY-180980 | H2N-PEG4-C2-Trizole-C3-COOH | / | Unkown | |
| HY-181040 | Factor B-IN-8 | Inhibitor | / | Unkown |
| HY-181062 | VWK147 | / | Unkown | |
| HY-181146 | MK-7762 | Inhibitor | / | Unkown |
| HY-181542 | SG-55 | / | Unkown | |
| HY-181918 | PLM-101-C3-NHBoc | / | Unkown | |
| HY-182978 | Pomalidomide-C3-O-C4-O-C3-NH2 | / | Unkown | |
| HY-183352 | BuChE-IN-23 | Inhibitor | / | Unkown |
| HY-184526 | HOOC-PEG5-N-(C3H7-isopropyl)-NH2 | / | Unkown | |
| HY-184537 | Desmethyl-QCA276-C3-alkyne | / | Unkown | |
| HY-186105 | P7C3-S243 | / | Unkown | |
| HY-186105A | (-)-P7C3-S243 | Inhibitor | / | Unkown |
| HY-19657S1 | Oxypurinol-13C3,15N3 | Inhibitor | / | Unkown |
| HY-19717S | DCVC-13C3,15N | / | Unkown | |
| HY-200854 | Iptacopan hydrochloride hydrate | Inhibitor | / | Unkown |
| HY-21191S | Perfluorobutanesulfonic acid-13C3 sodium | / | Unkown | |
| HY-21196S | Perfluorohexanesulfonic acid-13C3 sodium | / | Unkown | |
| HY-23506S | 1-Aminohydantoin-13C3 | / | Unkown | |
| HY-32349S3 | Ercalcidiol-13C3 | / | Unkown | |
| HY-32351B | 3-epi-Calcifediol | / | Unkown | |
| HY-40354S1 | Tofacitinib-13C3,15N | 99.57% | Unkown | |
| HY-42429 | CPI-203-PEG1-C3-O-COOH | / | Unkown | |
| HY-A0090S | Nitrofurantoin-13C3 | Inhibitor | / | Unkown |
| HY-A0132S5 | N-Acetyl-D-glucosamine-13C-3 | / | Unkown | |
| HY-A0132S9 | N-Acetyl-D-glucosamine-13C3,15N | / | Unkown | |
| HY-A0253S | Cefacetrile-13C3 | / | Unkown | |
| HY-B0143S4 | Niacin-15N,13C3 | / | Unkown | |
| HY-B0166S4 | L-Ascorbic acid-13C-3 | / | Unkown | |
| HY-B0388S | Probucol-13C3 | Inhibitor | / | Unkown |
| HY-B0389S18 | D-Glucose-13C3-1 | / | Unkown | |
| HY-B0495S4 | Lamotrigine-13C3 | / | Unkown | |
| HY-B0526S | Flumequine-13C3 | Inhibitor | / | Unkown |
| HY-B0636S1 | Triamcinolone acetonide-13C3 | / | Unkown | |
| HY-B1075AS | (Rac)-Fosfomycin (benzylamine)-13C3 | / | Unkown | |
| HY-B1331S1 | Cyromazine-13C3 | / | Unkown | |
| HY-B1449S4 | Uridine-13C-3 | / | Unkown | |
| HY-B1659AS | D-Glycerol-13C-3 | / | Unkown | |
| HY-B1659S | Glycerol-13C3,d8 | / | Unkown | |
| HY-B1890S | (±)-Catechin-13C3 | Inhibitor | / | Unkown |
| HY-B2235S | (Z,Z)-Lecithin-13C3 | / | Unkown | |
| HY-CE00612 | 2'-(5''-Phosphoribosyl)-3'-dephospho-CoA | / | Unkown | |
| HY-CE00614 | 2'-(5-Triphosphoribosyl)-3'-dephospho-CoA | / | Unkown | |
| HY-D1516 | NerveGreen C3 | / | Unkown | |
| HY-D1558 | 1,3,5,7-Tetramethyl-2,6-diiodo-C3-SE-BODIPYs | / | Unkown | |
| HY-D2200 | Cy5.5(Me)-C3-DBCO | / | Unkown | |
| HY-D3516 | 5-FAM C3 alkyne | / | Unkown | |
| HY-D3518 | Coumarin 343 C3 azide | / | Unkown | |
| HY-E70152 | ST6 Sialyltransferase 4 | / | Unkown | |
| HY-E71077 | (5R)-Carbapenem-3-carboxylate synthase | / | Unkown | |
| HY-N0001S | (±)-Epicatechin-13C3 | / | Unkown | |
| HY-N0055S | Chlorogenic acid-13C3 | / | Unkown | |
| HY-N0059S3 | D-Arabinose-13C-3 | / | Unkown | |
| HY-N0060S1 | Ferulic acid-13C3 | Inhibitor | 98.3% | Unkown |
| HY-N0086S3 | N6-Methyladenosine-13C3 | Inhibitor | / | Unkown |
| HY-N0210S2 | D-Galactose-13C-3 | / | Unkown | |
| HY-N0229S5 | L-Alanine-13C3,15N,d4 | 99.7% | Unkown | |
| HY-N0376R | Liquiritin (Standard) | / | Unkown | |
| HY-N0379S8 | D-Mannose-13C-3 | / | Unkown | |
| HY-N0382S | Galangin-13C3 | / | Unkown | |
| HY-N0521AS | (+)-Gallocatechin-13C3 | / | Unkown | |
| HY-N0683S1 | 2-ambo-Vitamin E-13C3 | Inhibitor | / | Unkown |
| HY-N10263 | Palmarumycin C3 | / | Unkown | |
| HY-N10519 | Cellooctaose | / | Unkown | |
| HY-N10998 | Chamaejasmenin A | / | Unkown | |
| HY-N11646 | Ganorbiformin B | Inhibitor | / | Unkown |
| HY-N1480S3 | (-)-Fucose-13C-3 | / | Unkown | |
| HY-N19814 | 3'-Deacetylfusicoccin A | / | Unkown | |
| HY-N1981S2 | Triolein-13C3-1 | / | Unkown | |
| HY-N2362S7 | DL-Alanine-13C3-4 | / | Unkown | |
| HY-N8847S | α-Ionone-13C3 | / | Unkown | |
| HY-P1142S | GLP-2(rat) (Ala-13C3,15N) | / | Unkown | |
| HY-P1142S1 | GLP-2(rat) (Ala-13C3,15N) TFA | / | Unkown | |
| HY-P11699 | AAPDNRETF | / | Unkown | |
| HY-P11857 | Alkyne-GRWHPM-CONH-NH-CMK | Inhibitor | / | Unkown |
| HY-P1345 | TLQP-21 | Agonist | / | Unkown |
| HY-P1345B | [DArg10, DAla20] TLQP-21 | / | Unkown | |
| HY-P1345C | [DArg10, Aib20] TLQP-21 | Antagonist | / | Unkown |
| HY-P1363S1 | β-Amyloid (1-42), human, Ala(13C3,15N) TFA | 99.57% | Unkown | |
| HY-P1398A | Compstatin control peptide TFA | Control | / | Unkown |
| HY-P2830 | Complement factor D | / | Unkown | |
| HY-P5071 | EcAMP3 | / | Unkown | |
| HY-R00006A | hsa-let-7c-3p agomir | / | Unkown | |
| HY-R00333A | hsa-miR-181c-3p agomir | / | Unkown | |
| HY-R00717A | hsa-miR-34c-3p agomir | / | Unkown | |
| HY-R00832 | hsa-miR-374c-3p mimic | / | Unkown | |
| HY-R00832A | hsa-miR-374c-3p agomir | / | Unkown | |
| HY-R00840A | hsa-miR-376c-3p agomir | / | Unkown | |
| HY-R01112A | hsa-miR-449c-3p agomir | / | Unkown | |
| HY-R01546 | hsa-miR-513c-3p mimic | / | Unkown | |
| HY-R01546A | hsa-miR-513c-3p agomir | / | Unkown | |
| HY-R01568A | hsa-miR-518c-3p agomir | / | Unkown | |
| HY-R01590 | hsa-miR-519c-3p mimic | / | Unkown | |
| HY-R01590A | hsa-miR-519c-3p agomir | / | Unkown | |
| HY-R01598 | hsa-miR-520c-3p mimic | / | Unkown | |
| HY-R01598A | hsa-miR-520c-3p agomir | / | Unkown | |
| HY-R01678A | hsa-miR-548c-3p agomir | / | Unkown | |
| HY-R02506 | hsa-miR-892c-3p mimic | / | Unkown | |
| HY-R02506A | hsa-miR-892c-3p agomir | / | Unkown | |
| HY-R02698A | mmu-miR-181c-3p agomir | / | Unkown | |
| HY-R02795 | mmu-miR-1970c-3p mimic | / | Unkown | |
| HY-R02795A | mmu-miR-1970c-3p agomir | / | Unkown | |
| HY-R02833 | mmu-miR-216c-3p mimic | / | Unkown | |
| HY-R02833A | mmu-miR-216c-3p agomir | / | Unkown | |
| HY-R02840 | mmu-miR-219c-3p mimic | / | Unkown | |
| HY-R02840A | mmu-miR-219c-3p agomir | / | Unkown | |
| HY-R02897A | mmu-miR-302c-3p agomir | / | Unkown | |
| HY-R03043 | mmu-miR-344c-3p mimic | / | Unkown | |
| HY-R03043A | mmu-miR-344c-3p agomir | / | Unkown | |
| HY-R03077 | mmu-miR-34c-3p mimic | / | Unkown | |
| HY-R03077A | mmu-miR-34c-3p agomir | / | Unkown | |
| HY-R03104 | mmu-miR-374c-3p mimic | / | Unkown | |
| HY-R03104A | mmu-miR-374c-3p agomir | / | Unkown | |
| HY-R03111 | mmu-miR-376c-3p mimic | / | Unkown | |
| HY-R03111A | mmu-miR-376c-3p agomir | / | Unkown | |
| HY-R03148 | mmu-miR-449c-3p mimic | / | Unkown | |
| HY-R03148A | mmu-miR-449c-3p agomir | / | Unkown | |
| HY-R03198 | mmu-miR-467c-3p mimic | / | Unkown | |
| HY-R03198A | mmu-miR-467c-3p agomir | / | Unkown | |
| HY-R03460 | mmu-miR-669c-3p mimic | / | Unkown | |
| HY-R03460A | mmu-miR-669c-3p agomir | / | Unkown | |
| HY-R04277 | rno-miR-196c-3p mimic | / | Unkown | |
| HY-R04277A | rno-miR-196c-3p agomir | / | Unkown | |
| HY-R04284 | rno-miR-200c-3p mimic | / | Unkown | |
| HY-R04284A | rno-miR-200c-3p agomir | / | Unkown | |
| HY-R04468 | rno-miR-449c-3p mimic | / | Unkown | |
| HY-R04468A | rno-miR-449c-3p agomir | / | Unkown | |
| HY-R04484 | rno-miR-466c-3p mimic | / | Unkown | |
| HY-R04484A | rno-miR-466c-3p agomir | / | Unkown | |
| HY-RI00006 | hsa-let-7c-3p inhibitor | / | Unkown | |
| HY-RI00006A | hsa-let-7c-3p antagomir | / | Unkown | |
| HY-RI00333A | hsa-miR-181c-3p antagomir | / | Unkown | |
| HY-RI00407A | hsa-miR-200c-3p antagomir | / | Unkown | |
| HY-RI00717 | hsa-miR-34c-3p inhibitor | / | Unkown | |
| HY-RI00717A | hsa-miR-34c-3p antagomir | / | Unkown | |
| HY-RI00832 | hsa-miR-374c-3p inhibitor | / | Unkown | |
| HY-RI00832A | hsa-miR-374c-3p antagomir | / | Unkown | |
| HY-RI00840A | hsa-miR-376c-3p antagomir | / | Unkown | |
| HY-RI01112 | hsa-miR-449c-3p inhibitor | / | Unkown | |
| HY-RI01112A | hsa-miR-449c-3p antagomir | / | Unkown | |
| HY-RI01546 | hsa-miR-513c-3p inhibitor | / | Unkown | |
| HY-RI01546A | hsa-miR-513c-3p antagomir | / | Unkown | |
| HY-RI01568 | hsa-miR-518c-3p inhibitor | / | Unkown | |
| HY-RI01568A | hsa-miR-518c-3p antagomir | / | Unkown | |
| HY-RI01590 | hsa-miR-519c-3p inhibitor | / | Unkown | |
| HY-RI01590A | hsa-miR-519c-3p antagomir | / | Unkown | |
| HY-RI01598 | hsa-miR-520c-3p inhibitor | / | Unkown | |
| HY-RI01598A | hsa-miR-520c-3p antagomir | / | Unkown | |
| HY-RI01678 | hsa-miR-548c-3p inhibitor | / | Unkown | |
| HY-RI01678A | hsa-miR-548c-3p antagomir | / | Unkown | |
| HY-RI02506 | hsa-miR-892c-3p inhibitor | / | Unkown | |
| HY-RI02506A | hsa-miR-892c-3p antagomir | / | Unkown | |
| HY-RI02698 | mmu-miR-181c-3p inhibitor | / | Unkown | |
| HY-RI02698A | mmu-miR-181c-3p antagomir | / | Unkown | |
| HY-RI02795 | mmu-miR-1970c-3p inhibitor | / | Unkown | |
| HY-RI02795A | mmu-miR-1970c-3p antagomir | / | Unkown | |
| HY-RI02833 | mmu-miR-216c-3p inhibitor | / | Unkown | |
| HY-RI02833A | mmu-miR-216c-3p antagomir | / | Unkown | |
| HY-RI02840 | mmu-miR-219c-3p inhibitor | / | Unkown | |
| HY-RI02840A | mmu-miR-219c-3p antagomir | / | Unkown | |
| HY-RI02897 | mmu-miR-302c-3p inhibitor | / | Unkown | |
| HY-RI02897A | mmu-miR-302c-3p antagomir | / | Unkown | |
| HY-RI03043 | mmu-miR-344c-3p inhibitor | / | Unkown | |
| HY-RI03043A | mmu-miR-344c-3p antagomir | / | Unkown | |
| HY-RI03077 | mmu-miR-34c-3p inhibitor | / | Unkown | |
| HY-RI03077A | mmu-miR-34c-3p antagomir | / | Unkown | |
| HY-RI03104 | mmu-miR-374c-3p inhibitor | / | Unkown | |
| HY-RI03104A | mmu-miR-374c-3p antagomir | / | Unkown | |
| HY-RI03111 | mmu-miR-376c-3p inhibitor | / | Unkown | |
| HY-RI03111A | mmu-miR-376c-3p antagomir | / | Unkown | |
| HY-RI03148 | mmu-miR-449c-3p inhibitor | / | Unkown | |
| HY-RI03148A | mmu-miR-449c-3p antagomir | / | Unkown | |
| HY-RI03198 | mmu-miR-467c-3p inhibitor | / | Unkown | |
| HY-RI03198A | mmu-miR-467c-3p antagomir | / | Unkown | |
| HY-RI03460 | mmu-miR-669c-3p inhibitor | / | Unkown | |
| HY-RI03460A | mmu-miR-669c-3p antagomir | / | Unkown | |
| HY-RI04277 | rno-miR-196c-3p inhibitor | / | Unkown | |
| HY-RI04277A | rno-miR-196c-3p antagomir | / | Unkown | |
| HY-RI04284 | rno-miR-200c-3p inhibitor | / | Unkown | |
| HY-RI04284A | rno-miR-200c-3p antagomir | / | Unkown | |
| HY-RI04468 | rno-miR-449c-3p inhibitor | / | Unkown | |
| HY-RI04468A | rno-miR-449c-3p antagomir | / | Unkown | |
| HY-RI04484 | rno-miR-466c-3p inhibitor | / | Unkown | |
| HY-RI04484A | rno-miR-466c-3p antagomir | / | Unkown | |
| HY-RS00536 | AKR1C3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01744 | C3AR1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS05969 | H3C3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS05976 | H4C3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS10520 | PIK3C3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS10522 | Pik3c3 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W007798S | Fmoc-Cys(Trt)-OH-1,2,3-13C3,15N | 98.7% | Unkown | |
| HY-W007926S | 2-Oxobutanoic acid-13C,d2-1 | / | Unkown | |
| HY-W009204S4 | Fmoc-Ala-OH-13C3,15N | 99.9% | Unkown | |
| HY-W010407S2 | Cyanuric acid-13C3,15N3 | / | Unkown | |
| HY-W010575S | (2R)-3-Amino-2-fluoropropanoic acid-13C3 | / | Unkown | |
| HY-W010596S | Malonamide-13C3 | / | Unkown | |
| HY-W013061S11 | Tripalmitin (Glycerol 13C3,13C 99%) | / | Unkown | |
| HY-W013061S4 | Propane-1,2,3-triyl tripalmitate-13C3-1 | / | Unkown | |
| HY-W015084S | β-Ionone-13C3 | Inducer | / | Unkown |
| HY-W017529S | 6-Chloro-1,3,5-triazine-2,4-diamine-13C3 | / | Unkown | |
| HY-W017540S | Cyclocreatine-13C3 | / | Unkown | |
| HY-W018772S4 | D-Ribose-13C-3 | 99.9% | Unkown | |
| HY-W096151 | Chloroacetamido-C-PEG3-C3-NHBoc | / | Unkown | |
| HY-W127393 | N-Nonanoyl-L-homoserine lactone | / | Unkown | |
| HY-W127487 | N-Octadecanoyl-L-homoserine lactone | / | Unkown | |
| HY-W269693S | 5-(4-Hydroxyphenyl)-5-phenylimidazolidine-2,4-dione-13C3,d5 | / | Unkown | |
| HY-W324220 | 11β-HSD1-IN-10 | / | Unkown | |
| HY-W357090S | L-Idose-13C-3 | / | Unkown | |
| HY-W456457 | Tetrapyrido[3,2-a:2',3'-c:3'',2''-h:2''',3'''-j]phenazine | / | Unkown | |
| HY-W584535 | VH032-C3-Boc | / | Unkown | |
| HY-W585905 | Trimethylammonium chloride-13C3 | / | Unkown | |
| HY-W591717 | EM-12-alkyne-C3-NH2 | / | Unkown | |
| HY-W653931 | rac 1,2-Bis-palmitoyl-3-chloropropanediol-13C3 | / | Unkown | |
| HY-W653989 | Desonide-13C3 | / | Unkown | |
| HY-W654296 | Octocrylene-13C3 | / | Unkown | |
| HY-W706737 | N-Deschlorobenzoyl indomethacin-d3 | / | Unkown | |
| HY-W718035S | 1-Chloro-3-(octanoyloxy)propan-2-yl decanoate-13C3 | / | Unkown | |
| HY-W718041S | 1-Lauroyl-2-decanoyl-3-chloropropanediol-13C3 | / | Unkown | |
| HY-W747791 | 4,6-Dichloro-1,3,5-triazin-2-amine-13C3 | / | Unkown | |
| HY-W748430 | Furagin-13C3 | / | Unkown | |
| HY-W748519 | Sarcosine-13C3 | / | Unkown | |
| HY-W749145 | 2-Chloro-5-thiazolecarboxylic Acid-13C3,15N | / | Unkown | |
| HY-W749394 | 4-Methyl-5-thiazoleethanol-13C3 | / | Unkown | |
| HY-W749519 | (E,E)-Farnesol-13C3 | / | Unkown | |
| HY-W749742 | Isopropyltriphenylphosphonium bromide-13C3 | / | Unkown | |
| HY-W749783 | 1-Decanoyl-2-octanoyl-3-chloropropanediol-13C3 | / | Unkown | |
| HY-W749786 | 1-Decanoyl-2-lauroyl-3-chloropropanediol-13C3 | / | Unkown | |
| HY-W750553 | 2-Ethylhexyl 2-cyanoacetate-13C3 | / | Unkown | |
| HY-W751156 | O-Phospho-L-serine-13C3 | / | Unkown | |
| HY-W751753 | Ethyl (2-cyanoacetyl)carbamate-13C3,15N | / | Unkown | |
| HY-W751756 | 6-Cyano Diclazuril-13C3,15N2 | / | Unkown | |
| HY-W751808S | 2,3-Diphosphoglyceric acid-13C3 | / | Unkown | |
| HY-W751832 | 5,6-Diaminopyrimidine-2,4-diol hydrochloride-13C3 | / | Unkown | |
| HY-W751834 | 6-Amino-5-nitropyrimidine-2,4(1H,3H)-dione-13C3 | / | Unkown | |
| HY-W753497 | Benzene-1,2,4-tricarboxylic acid-13C3 | / | Unkown | |
| HY-W754236 | (R)-Carnitine Hydrochloride-13C3 | / | Unkown | |
| HY-W756586 | Rac 2-stearoyl-3-chloropropanediol-13C3 | / | Unkown | |
| HY-W756589 | Rac 2-linolenoyl-3-chloropropanediol-13C3 | / | Unkown | |
| HY-W759219 | Adrenosterone-13C3 | / | Unkown | |
| HY-W759459 | Meldrum's acid-13C3 | / | Unkown | |
| HY-W765177 | Acetyl-L-carnitine hydrochloride-13C3 | / | Unkown | |
| HY-W766603 | Thiouric Acid Sodium Salt Dihydrate-13C3 | / | Unkown | |
| HY-W768226 | D-Fructose-1,2,3-13C3 | / | Unkown | |
| HY-W768527 | Methyl piperidine-4-carboxylate hydrochloride-13C3 | / | Unkown | |
| HY-W768964 | a,a-Dimethyl-1H-indole-2-acetonitrile-13C315N | / | Unkown | |
| HY-W768990 | Vinclozolin-13C3,d3 | / | Unkown | |
| HY-W769556 | Ethyl Cyano(ethoxymethylene)acetate-13C3 | / | Unkown | |
| HY-W770279 | DL-Cytarabine-13C3 | / | Unkown | |
| HY-W770914 | Stearoyl-L-carnitine chloride-13C3 | / | Unkown | |
| HY-W776973 | Glycidamide-13C3 | / | Unkown | |
| HY-W777002 | Famotidine-13C3 | / | Unkown | |
| HY-W777084 | (E)-3,4-Dimethoxycinnamic acid-13C3 | / | Unkown | |
| HY-W777266 | Cyclohexane-1,3-dione-13C3 | / | Unkown | |
| HY-W777281 | Fluocinolone acetonide-13C3 | / | Unkown | |
| HY-W777340 | Gimeracil-13C3 | / | Unkown | |
| HY-W777351 | Etravirine-13C3 | / | Unkown | |
| HY-W777615 | Ammeline Hydrochloride-13C3 | / | Unkown | |
| HY-W777751 | 6-Desamino 6-chloro etravirine-13C3 | / | Unkown | |
| HY-W777806 | Pyrimido[1,2-a]purin-10(1H)-one-13C3 | / | Unkown | |
| HY-W777836 | 2,2-Dibromomalonamide-13C3 | / | Unkown | |
| HY-W777862 | 1-Stearoyl-rac-glycerol-13C3,d5 | / | Unkown | |
| HY-W778057 | Ethyl 3,4-Dihydroxybenzoate-13C3 | / | Unkown | |
| HY-W778286 | Enterolactone-13C3 | / | Unkown | |
| HY-W778288 | (±)-Enterodiol-13C3 | / | Unkown | |
| HY-W778511 | Levulinic acid-13C3 | / | Unkown | |
| HY-W778954 | 2,2-Dimethyl-1,3-dioxolane-4-methanol-13C3 | / | Unkown | |
| HY-W779236 | Ethyl Propargylate-13C3 | / | Unkown | |
| HY-W946627 | (S,R,S)-AHPC-Me-amide-C-O-C3-PEG1-NH2 | / | Unkown | |
| HY-Y0418S3 | Dulcite-13C-3 | / | Unkown | |
| HY-Y0504S | Trimethylammonium chloride-13c3,d9 | 98% | Unkown | |
| HY-Y0659S1 | 1,2,3,4-Hydroquinoline-13C3,15N | / | Unkown | |
| HY-Y0921S3 | (±)-1,2-Propanediol-13C3 | / | Unkown | |
| HY-Y1117S1 | Melamine-13C3 | 98.71% | Unkown | |
| HY-10002S | Calcitriol-13C3 | Inhibitor | 97.0% | Unkown |
| HY-100840 | (S)-4C3HPG | / | Unkown | |
| HY-100840A | (RS)-4C3HPG | Antagonist | / | Unkown |
| HY-112251S | D-Lin-MC3-DMA-13C3 | / | Unkown | |
| HY-115767S | (±)-1,2-Diolein-13C3 | Activator | / | Unkown |
| HY-119051 | BR111 | / | Unkown | |
| HY-122585 | proMMP-9 inhibitor-3c | Inhibitor | / | Unkown |
| HY-124432 | CRT0093964 | Inhibitor | / | Unkown |
| HY-125485 | Fmoc-C-PEG3-C3-Succinamic acid | / | Unkown | |
| HY-127035S1 | Tristearin-13C3 | / | Unkown | |
| HY-137225 | HTS07944 | / | Unkown | |
| HY-139227 | Thalidomide 4'-oxyacetamide-C1-PEG3-C3-amine hydrochloride | Inducer | / | Unkown |
| HY-144344S | Benzyl(2R)-3-N,N-dibenzylamino-2-fluoropropanoate-13C3 | / | Unkown | |
| HY-148637 | Picoberin | Agonist | / | Unkown |
| HY-149749 | Methylthiomcresol-C3-COOH | / | Unkown | |
| HY-150532S | (Rac)-Vitamin B5,Calcium Salt Hydrate-13C3 15N | / | Unkown | |
| HY-154746S | 3-HPMA Potassium Salt-3-13C3,15N | / | Unkown | |
| HY-154814S | Monohydroxy-3-butenyl-mercapturic acid-13C3,15N sodium | / | Unkown | |
| HY-159145 | Lenalidomide-acetylene-C3-MsO | / | Unkown | |
| HY-161652 | Thalidomide-NH-C3-O-Ph(NO2)-methylester-O-pyrrolidine-2,5-dione | / | Unkown | |
| HY-161656 | PIP-C-3-Azaspiro[5.5]undecane-boc | / | Unkown | |
| HY-163267 | ZNL0325 | / | Unkown | |
| HY-163647 | Lenalidomide-COCH-PEG2-azido | / | Unkown | |
| HY-165686 | Benalaxyl metabolite M2-13C3 | / | Unkown | |
| HY-168192 | Thalidomide-NH-C4-amide-C3-Br | / | Unkown | |
| HY-168380 | Lipid C3 | / | Unkown | |
| HY-172223 | 3-Deazaguanosine | Inhibitor | / | Unkown |
| HY-172296 | Biotinamide-C3-PEG3-C-alkyne | / | Unkown | |
| HY-173103S | FYDPL(Ala-13C3,15N)GK TFA | / | Unkown | |
| HY-17469S | Gimeracil-13C3,15N | / | Unkown | |
| HY-175506 | RyRs activator 6 | / | Unkown | |
| HY-175948 | Lenalidomide-CO-C3-NH-alkynes | / | Unkown | |
| HY-176038 | MS1262-C3-amide-C10-amine | / | Unkown | |
| HY-176893 | Mm-C3-OSu | / | Unkown | |
| HY-180767 | Azithromycin-amide-C3-amide-quinoxaline | Inhibitor | / | Unkown |
| HY-182222 | 5'-Amino-modifier C3-TFA | / | Unkown | |
| HY-186237 | Fuc(1→2)-Gal(3→1)(C3-amide-C5-biotin)-GalNAc | / | Unkown | |
| HY-41700S5 | D-Alanine-13C3 | / | Unkown | |
| HY-B0111RS | Drospirenone-13C3 | / | Unkown | |
| HY-B0399S2 | L-Carnitine-13C3 | / | Unkown | |
| HY-B0510S3 | Trimethoprim-13C3 | Inhibitor | / | Unkown |
| HY-D0205AS1 | Carbocisteine-13C3-1 | / | Unkown | |
| HY-N0001S2 | (-)-Epicatechin-13C3 | / | Unkown | |
| HY-N0092S4 | Inosine-13C3 | Agonist | / | Unkown |
| HY-N0230S5 | β-Alanine-13C | / | Unkown | |
| HY-N0368S1 | Linalool-13C3 | / | Unkown | |
| HY-N0803S1 | Myrcene-13C3 | Inhibitor | / | Unkown |
| HY-N1071 | Wilforol C | / | Unkown | |
| HY-N12816 | Glaucogenin C 3-O-α-L-cymaropyranosyl-(1→4)–β-D-digitoxopyranosyl-(1→4)-β-D-canaropyranoside | / | Unkown | |
| HY-N14052 | Arizonin C3 | Inhibitor | / | Unkown |
| HY-N14105 | Cinatrin C3 | Inhibitor | / | Unkown |
| HY-N14419 | Salfredin C3 | Inhibitor | / | Unkown |
| HY-N14460 | Pluracidomycin C3 | Inhibitor | / | Unkown |
| HY-N14691 | Platenomycin C3 | Inhibitor | / | Unkown |
| HY-N1849 | 3'-Methoxyrocaglamide | / | Unkown | |
| HY-N5181 | Parvodicin C3 | Inhibitor | / | Unkown |
| HY-N7091S1 | Atrazine-13C3,15N3 | / | Unkown | |
| HY-N7092S22 | D-Fructose-13C3 | / | Unkown | |
| HY-N7092S23 | D-Fructose-13C3-1 | / | Unkown | |
| HY-N9332 | Kalopanax saponin G | / | Unkown | |
| HY-N9522 | β-D-glucopyranosyl-[α-L-rhamnopyranosyl-(1→3)-βD-glucuronopyranosyl-(1→3)]-3β-hydroxyolean-12-ene28-oate | 99.95% | Unkown | |
| HY-P0058S | Pramlintide-(Ala-13C3,15N) | / | Unkown | |
| HY-P1624S | Teduglutide-Ala(13C3,15N) sodium | / | Unkown | |
| HY-P6696S | β-CL, Ala(13C3,15N) TFA | / | Unkown | |
| HY-R04628 | mmu-miR-200c-3p mimic | / | Unkown | |
| HY-RI04615 | mmu-miR-200c-3p inhibitor | / | Unkown | |
| HY-RS16401 | NT5C3A Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS16520 | C3 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS22951 | C3 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23044 | Akr1c3 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS27683 | Nt5c3a Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS28019 | C3ar1 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W007941S | Fmoc-Ser(tBu)-OH-13C3,15N | 99.5% | Unkown | |
| HY-W009204S5 | Fmoc-Ala-OH-13C3 | Modulator | 98.5% | Unkown |
| HY-W012578S1 | 2-Isopropyl-3-methoxypyrazine-13C3 | / | Unkown | |
| HY-W012932S | 2,4-Dimethylthiazole-13C3 | / | Unkown | |
| HY-W020044S | DL-alpha-Tocopherol-13C3 | Inhibitor | / | Unkown |
| HY-W021040S | Fludioxonil-13C3 | / | Unkown | |
| HY-W091039S | N-Acetyl-α-neuraminic acid-13C3 | / | Unkown | |
| HY-W1110947 | (S)-3-Phosphoglyceric acid-13C3 sodium | / | Unkown | |
| HY-W1113139 | H2N-PEG4-C3-OH | / | Unkown | |
| HY-W115358 | Piperazin-C3-OH dihydrochloride | / | Unkown | |
| HY-W128657S | 3-Chloro-2-hydroxypropanoic acid-13C3 | / | Unkown | |
| HY-W130878 | 4-Octylphenol | Activator | / | Unkown |
| HY-W156840S | OTNE-13C3 | / | Unkown | |
| HY-W190925 | APN-C3-biotin | / | Unkown | |
| HY-W339437 | NH2-C3-PEG2-NH2 | / | Unkown | |
| HY-W440913 | DSPE-PEG5000-Cy5 | / | Unkown | |
| HY-W585819S | 3-Chloropropane-1,2-diol dipalmitate-13C3 | / | Unkown | |
| HY-W653853 | Ritonavir-13C3 | / | Unkown | |
| HY-W654120 | Creatine-13C3 | / | Unkown | |
| HY-W654126 | Cytarabine-13C3 | / | Unkown | |
| HY-W654127 | Cytarabine-13C3 5'-monophosphate | / | Unkown | |
| HY-W654156 | Diclazuril-13C3,15N2 | Inhibitor | / | Unkown |
| HY-W654362 | (R)-2-Thioxothiazolidine-4-carboxylic acid-13C3 | / | Unkown | |
| HY-W743781 | N-Nitrosonornicotine-d4 | / | Unkown | |
| HY-W747639 | Glycidyl Stearate-13C3 | / | Unkown | |
| HY-W748200 | 3-Hydroxypropionic acid-13C3 sodium | / | Unkown | |
| HY-W749516 | Voglibose-13C3 | Inhibitor | / | Unkown |
| HY-W749756 | rac-1,2-Distearoyl-3-chloropropanediol-13C3 | / | Unkown | |
| HY-W751098 | Aldosterone-13C3 | / | Unkown | |
| HY-W751099 | Corticosterone-13C3 | / | Unkown | |
| HY-W767866 | N-Acetyl-S-(2-carboxyethyl)cysteine-13C3 dicyclohexylamine | / | Unkown | |
| HY-W769714 | Favipiravir-13C3 | Inhibitor | / | Unkown |
| HY-W770183 | Uric acid-13C3 | / | Unkown | |
| HY-W777148 | Anagrelide-13C3 | / | Unkown | |
| HY-W923498 | Boc-NH-C3-O-Propargyl | / | Unkown | |
| HY-W998285 | Pomalidomide-C3-alkyne | / | Unkown | |
| HY-W998298 | (S,R,S)-AHPC-C5-PEG3-C3 | / | Unkown | |
| HY-W998312 | Thalidomide-O-amido-C3-COOH TFA | / | Unkown | |
| HY-W998315 | (S,R,S)-AHPC-Me-CO-C3-COOH | / | Unkown | |
| HY-W998328 | Thalidomide-O-amido-C3-NH2 hydrochloride | / | Unkown | |
| HY-109506S10 | DPPC-13C3 | / | Unkown | |
| HY-P3252AS | Pegcetacoplan-13C3,15N TFA | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(8)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P990216 | Anti-Mouse IL-25 Antibody (2C3) | Inhibitor | 95.00% | Unkown |
| HY-P991706 | Nelvutamig | Inhibitor | 97.76% | Unkown |
| HY-P99905 | Efdamrofusp alfa | 99.89% | Unkown | |
| HY-P990955 | Ebribafusp alfa | Inhibitor | 96.40% | Unkown |
| HY-P992456 | SAR-443809 | Inhibitor | / | Unkown |
| HY-P991590 | 1D09C3 | / | Unkown | |
| HY-P991936 | Anti-CEACAM5/CEA/CD66e Antibody (16C3) | / | Unkown | |
| HY-P992470 | STT-5058 | Inhibitor | / | Unkown |